TMDI - Titan Medical Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 566.52M
Enterprise Value 343.36M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.85

Trading Information

Stock Price History

Beta (3Y Monthly) 4.77
52-Week Change 3-35.88%
S&P500 52-Week Change 36.70%
52 Week High 34.6500
52 Week Low 31.0500
50-Day Moving Average 32.2865
200-Day Moving Average 32.8214

Share Statistics

Avg Vol (3 month) 3138.72k
Avg Vol (10 day) 387.28k
Shares Outstanding 5380.6M
Float 30.93M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Jun 28, 2019) 4619.83k
Short Ratio (Jun 28, 2019) 43.24
Short % of Float (Jun 28, 2019) 4N/A
Short % of Shares Outstanding (Jun 28, 2019) 41.99%
Shares Short (prior month May 31, 2019) 4471.39k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 230/1
Last Split Date 3Jun 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-103.18%
Return on Equity (ttm)-2,132.90%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -50.78M
Net Income Avi to Common (ttm)-50.11M
Diluted EPS (ttm)-2.6020
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.61M
Total Cash Per Share (mrq)0.76
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.86
Book Value Per Share (mrq)-0.15

Cash Flow Statement

Operating Cash Flow (ttm)-54.95M
Levered Free Cash Flow (ttm)-13.34M